Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences NanoPharmaceuticals

Manika Pal Bhadra's Biography



Manika Pal Bhadra, Principal Scientist, Indian Institute of Chemical Technology

Dr. Manika Pal Bhadra is an eminent and one of the well reputed scientists in India. She is presently working as a principal scientist and Head of the division Centre for Chemical Biology at CSIR-Indian Institute of Chemical Technology, Hyderabad. She was awarded Ph. D in the area of Adv. Cytology and Mol. Genetics from Calcutta University, India and Post Doctorial studies at University of Missouri, Columbia. She has 96 research publications in international Journals like Cell, Science, Molecular Cell, Gene, Nature Genetics, Nanotechnology etc. in the areas of RNAi & Epigenetic, Nanotechnology and Drug discovery. She is currently handling various in-house and international projects which include i) Role Of RNAi on heterochromatin silencing and its assembly in Drosophila. ii) Screening and development of novel drug targets that act as histone deacetylases inhibitors iii) Development and biological evaluation of nanoparticles for targeted delivery of siRNA to cells. iv) Screening of biological evaluation of small molecule modifiers of micro RNA. She is recipient of several prestigious awards like Nasi Reliance-2012, Wellcome Trust Fellow-2005, IICT Best Women Scientist-2012, IICT Roll of Honour-2007 and Young Scientist Award-1991 to her credit.

Manika Pal Bhadra Image

Para Amino Benzoic Acid derived Self Assembled Biocompatible Nanoparticle for Efficient Delivery of siRNA

Friday, 11 September 2015 at 14:45

Add to Calendar ▼2015-09-11 14:45:002015-09-11 15:45:00Europe/LondonPara Amino Benzoic Acid derived Self Assembled Biocompatible Nanoparticle for Efficient Delivery of siRNANanoPharmaceuticals in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com

The Keynote Talk will discuss the development of functionalized biocompat┬Čible fluorescent nanoparticles from para amino benzoic acid nanoparticles for efficient delivery of short interfering RNA (siRNA). Further, it will report that these nanoparticles are non-toxic and did not interfere with progression of the cell cycle. Finalli, it will highlight that the intrinsic fluorescent nature of these nanoparticles allows easy tracking and an opportunity for diagnostic applications.


Add to Calendar ▼2015-09-10 00:00:002015-09-11 00:00:00Europe/LondonNanoPharmaceuticalsNanoPharmaceuticals in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com